Risk factors for the development of depression in patients with hepatitis C taking interferon-α
Kimberley J Smith¹, Suzanne Norris², Cliona O'Farrelly³, O'Mara SM¹¹Trinity College Institute of Neuroscience, ²Hepatology Centre, St James's Hospital, Dublin, Ireland; ³Dep...
Main Authors: | Smith KJ, Norris S, O'Farrelly C, O'Mara SM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-05-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/risk-factors-for-the-development-of-depression-in-patients-with-hepati-a7460 |
Similar Items
-
Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis
by: O'Regan C, et al.
Published: (2012-02-01) -
Patient assessment of an electronic device for subcutaneous self-injection of interferon ß-1a for multiple sclerosis: an observational study in the UK and Ireland
by: D'Arcy C, et al.
Published: (2012-01-01) -
Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes
by: Richard D O'Connor
Published: (2011-01-01) -
Review of consensus interferon in the treatment of chronic hepatitis C
by: Th Witthöft
Published: (2008-09-01) -
Hypertension and obstructive sleep apnea
by: Phillips CL, et al.
Published: (2013-05-01)